Company Filing History:
Years Active: 2004-2006
Title: Innovations by Yoshiji Yamada in Metabolic Bone Disease Diagnosis
Introduction
Yoshiji Yamada is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of metabolic bone diseases. With a total of 2 patents to his name, Yamada's work is instrumental in advancing healthcare solutions.
Latest Patents
Yamada's latest patents include a method of diagnosing metabolic bone diseases, especially osteoporosis and arthrosis. This method is characterized by determining the concentration of osteoclastgenesis inhibitory factor (OCIF) in humor. His innovations involve monoclonal antibodies that recognize both the monomer and dimer types of OCIF, as well as those that selectively recognize the dimer type. Additionally, he has developed an assay kit for determining OCIF concentration, which comprises two antibodies that recognize different epitopes of OCIF and exhibit high affinity, with a dissociation constant of less than 2×10M with the antigen. This method is particularly useful for diagnosing metabolic bone diseases and serves as an assay reagent for related research.
Career Highlights
Yoshiji Yamada is currently associated with Sankyo Company, Limited, where he continues to innovate in the field of medical diagnostics. His work has garnered attention for its potential impact on the diagnosis and treatment of bone-related diseases.
Collaborations
Yamada collaborates with talented individuals such as Kazuki Yano and Fumie Kobayashi, contributing to a dynamic research environment that fosters innovation.
Conclusion
Yoshiji Yamada's contributions to the field of metabolic bone disease diagnosis highlight the importance of innovation in healthcare. His patents and ongoing work at Sankyo Company, Limited, reflect a commitment to improving diagnostic methods and patient outcomes.